retatrutide phase 2 diabetes weight loss 2024 New 3 data just dropped 👀 Eli Lilly's trial reported average approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Eli Lilly infiltrates anti-obesity market

If you have a health savings account or a flexible spending account, you can use it to pay for them with pretax dollars

In Phase 2 clinical trials (NEJM, 2023), retatrutide was administered as a once-weekly subcutaneous injection , following a structured dose-escalation schedule

Week 1-4: 0.25 mg once weekly Weeks 5-8: 0.5 mg once weekly Weeks 9-12 (if needed): 1 mg once weekly, if further glycemic control is required Week 13 onwards (if needed): 2 mg once weekly, if your body can tolerate the previous dosage and further glycemic control is required This medication is started at 0.25 mg per week until you reach the maintenance dose

Unlike some other GLP-1 medications, which require daily injections, Ozempics weekly administration greatly enhances convenience, comfort, and patient compliancecritical factors in achieving long-term weight loss success

However, by designing around patents before filing and using Section viii statements for method-of-use carve-outs, some applicants can minimize the likelihood of a successful stay

For investigational compounds such as retatrutide, reconstitution instructions are specified in the trial protocol and IMPD, and are followed by trained trial site staff